Journal of microbiology, epidemiology and immunobiology
The Journal is published on behalf of the Russian scientific and practical society of epidemiologists, microbiologists and parasitologists.
This Platinum Open Access peer-reviewed Journal intends to publish the cutting edge research results focused on control of spread, prevention and treatment of human infectious diseases in the field of medical microbiology, virology, epidemiology, immunology including immunodiagnostics and immunoprophylaxis.
The Journal covers the issues of human infectious diseases from the point of research of pathogen — bacteria, viruses and prions in relationship to the human immune response, intra- and interspecific interaction, environment, as well as related evolutionary processes and public health.
The Journal is intended for professionally interested physicians, epidemiologists, researchers, university lecturers, postgraduates and students.
The Journal accepts for publication Russian and foreign original research articles, reviews, short communications, mini reviews, opinion and other special featured articles as well as lectures, methodological materials related to its profile.
All papers are subject to mandatory double-blind review.
The Journal does not charge authors any fees.
JMEI belongs to the IV quartile of SJR (2022) in the specialties Epidemiology, Immunology, Immunology and Microbiology (miscellaneous), Virology and to the III quartile in the specialty Medicine (miscellaneous), is included in international bibliographic systems and international citation databases: SCOPUS, DOAJ, ULRICHS PERIODICAL DIRECT, EBSCO, OPENALEX, Fatcat, RSCI, RUSMED, ZEITSCHRIFTEN DATENBANK, GOOGLE SCHOLAR, CYBERLENINKA, RUCONT, to the recommended by Higher Attestation Commission “List of peer-reviewed scientific publications in which the main scientific results of dissertations for the degree of candidate of science should be published, competition for the scientific degree of Doctor of Science" in the following specialties:
- 03.02.02 Virology (medical and biological sciences)
- 03.02.03 Microbiology (medical and biological sciences)
- 14.02.02 Epidemiology (medical and biological sciences)
- 14.03.09 Clinical immunology, Allergology (medical and biological sciences).
In accordance with the recommendations of the Higher Attestation Commission (Letter of the Higher Attestation Commission dated December 06, 2022 No. 02-1198), the Journal belongs to the K1 category, as a publication included in the SCOPUS and RSCI databases.
The Journal follows the ICMJE's Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals.
The Journal is presented in the following online sci-hub libraries and abstract and citation databases:
- SCOPUS
- DOAJ
- ULRICHS PERIODICAL DIRECT
- Russian Science Citation Index (RSCI)
- Google Scholar
- CYBERLENINKA
- RUCONT
The most significant articles by the decision of the Editorial Board are published in full-text translation on the Journal's website under the same DOI as the original.
Each article of the Journal is assigned a digital object identifier — DOI (Crossref).
The content is available under the Creative Commons — Attribution 4.0 International, CC-BY license.
![]()
The CrossMark service is used to keep the content of the Journal up-to-date and to inform readers about changes in published articles if they occur.

The Journal uses Online First Pre-Publication — the online publication of the final version of an article that has been reviewed and accepted for publication in the Journal, without waiting for placement in a specific issue and pagination. DOI are assigned to the articles, which makes it possible to fully cite before the publication of the Journal issue.
The Editorial Board consists of 24 leading Russian and 8 foreign microbiologists, virologists, immunologists and infectious diseases doctors, including 11 full members and 6 corresponding members of the Russian Academy of Sciences.
All papers are subject to mandatory double-blind review.
The Journal is registered by the Federal service for supervision of communications, information technology and mass communications. Certificate of PI NOFS77-75442.
The Journal publishes regular issues bimonthly, six times per year.
Founders:
- Central Research Institute for Epidemiology
- Russian Scientific Society of Epidemiologists, Microbiologists and Parasitologists
Publisher:
- Central Research Institute for Epidemiology
Current Issue
Vol 103, No 2 (2026)
- Year: 2026
- Published: 13.05.2026
- Articles: 12
- URL: https://microbiol.crie.ru/jour/issue/view/195
Full Issue
REVIEWS
The possibilities of using HIV-1 molecular cluster analysis to study the epidemic process of HIV infection
Abstract
Surveillance of human immunodeficiency virus type 1 (HIV-1) infection has a number of limitations related to the long-term asymptomatic course of the disease, a high level of stigmatization of HIV-infected individuals, as well as the difficulty of collecting information on the mechanisms of HIV-1 transmission. In these conditions, genomic surveillance is becoming important, which allows for obtaining objective data on the structure and dynamics of the epidemic process. One of the main tools of genomic surveillance is the analysis of HIV-1 molecular clusters. This review presents the possibilities of using the analysis of HIV-1 molecular clusters to study the features of the epidemic process of HIV infection, as well as describes the methodological and ethical aspects of using this method in the system of surveillance of HIV infection.
161-170
Rotavirus infection: current state and prospects for control using RNA technologies
Abstract
Background. Rotavirus infection remains the leading cause of severe gastroenteritis in children under 5 years of age, particularly in low-income countries. Existing live oral vaccines have reduced efficacy in regions with high infection rates, and there is no etiological treatment available. Consequently, new platforms are being actively investigated: mRNA vaccines (capable of overcoming maternal antibody interference) and RNA interference (allowing for direct suppression of viral replication).
The aim of this review is to systematize data on the molecular mechanisms of rotavirus replication and pathogenesis, epidemiology, and diagnosis, as well as to provide a comparative analysis of current vaccines and promising RNA technologies (mRNA vaccines, RNA interference) for the prevention and treatment of rotavirus infection.
Objectives: to describe the structure and replication of the virus, the epidemiological situation, and diagnostic methods; to evaluate existing vaccines; and to analyze two areas of RNA technology: mRNA vaccines, as prevention, and RNA interference, as therapy based on siRNA, miRNA, and lncRNA.
Conclusions. Conventional vaccines remain the foundation of mass vaccination programs, despite their limitations. mRNA vaccines (especially trivalent ones based on VP8*) induce durable humoral and cellular immunity in preclinical studies, overcoming maternal antibody interference. RNA interference (siRNA, miRNA) allows for direct suppression of viral replication. However, at present, no mRNA candidate vaccine has advanced to the clinical trial phase. Further research is needed to improve vaccine delivery systems and increase its thermal stability.
171-189
ORIGINAL RESEARCHES
Identification and multiparametric ranking of candidate genes involved in hepatitis C virus entry and host immune response using bioinformatics methods
Abstract
Introduction. Hepatitis C virus (HCV) remains a significant public health concern. The application of existing antiviral agents is restricted by their high cost and the development of viral resistance, while vaccine development is impeded by the considerable genetic variability of HCV. The outcome of infection is largely determined by the host's genetic factors, which influence both the viral entry into the cell and the effectiveness of antiviral immunity. Identification of genetic determinants involved in these processes is essential for understanding pathogenesis and discovering novel therapeutic targets.
Objective. A comprehensive assessment of the potential involvement of candidate genes and their products in the pathogenesis of HCV infection at the stages of viral entry into the cell and the formation of the host immune response, based on an integrative analysis of gene expression, subcellular localization of their products, and participation in molecular pathways and biological processes.
Materials and methods. In this study, a comparative analysis of 35 most promising candidate genes was performed against five background genes (CD81, CLDN1, LDLR, OCLN, SCARB1) encoding key HCV entry receptors. To analyze biological mechanisms associated with priority genes, the FUMA GWAS platform was used in the functional mapping mode GENE2FUNC (https://fuma.ctglab.nl/gene2func). Evaluation of candidate genes included analysis of their expression profiles, subcellular localization of protein products, as well as involvement in molecular pathways and biological processes. A ranking scoring system was developed, based on point-based ranking, which allowed determining the significance of each candidate gene in the context of its potential involvement in HCV pathogenesis. The system includes sequential assessment by several independent criteria, the results of which are summed into a single score. The degree of association between candidate genes and background genes was assessed using the phi-correlation coefficient (φ) across categories of subcellular localization, molecular pathways, and biological processes.
Results. Application of the developed scoring system identified 25 significant candidate genes. The highest scores were obtained for genes involved in intercellular junction organization (CLDN3, CLDN5, CLDN12, ESAM, F11R, TJP1, TJP2) and lipid metabolism regulation (APOE, LDLRAP1). Enrichment of several candidate genes in immunological processes was revealed. A stable association of C3 and CD19 genes with immune process regulation was established, which is of particular interest in light of HCV's ability to infect mononuclear cells. The APOE, ITGB1, F11R genes demonstrated involvement in inflammatory and defense responses, while IFITM1 was associated with response to cytokine stimulation.
Conclusion. A group of candidate genes potentially influencing HCV infection pathogenesis both at the viral entry stage and through immune modulation was identified. The obtained data expand understanding of virus-host interactions and justify the need for experimental validation of the identified genes as potential biomarkers and therapeutic targets.
190-204
Attenuated Omicron-like SARS-CoV-2 strain
Abstract
Introduction. The severe consequences of the COVID-19 pandemic highlight the lack of preparedness of national health systems to counter such biological threats. In this regard, the development of preventive means for specific prophylaxis of COVID-19 and other coronavirus diseases remains urgent.
The aim of the study was to obtain an attenuated Оmicron-like SARS-CoV-2 strain to create a preventive live attenuated COVID-19 vaccine.
Materials and methods. For SARS-CoV-2 infection modeling in vitro and virus propagation, Vero CCL-81 cell culture as well as laboratory strains SARS-CoV-2 Dubrovka (Wuhan-like) and FEB2 (Omicron BA.5.2) were used. Attenuation of the FEB2 strain was carried out by cultivation for 24 passages in Vero CCL-81 cells at a temperature gradually lowered to 24°C, followed by triple cloning. COVID-19 modeling in vivo was performed on golden Syrian hamsters. Viral load was assessed by virus titration by the CPE endpoint and SARS-CoV-2 RNA quantitation in real-time RT-PCR. The primary structure of the SARS-CoV-2 genome was determined by nanopore sequencing. Antibodies to SARS-CoV-2 in hamster sera were detected by ELISA.
Results. A non-pathogenic for Syrian hamsters temperature-sensitive (ts) mutant of the omicron-like SARS-CoV-2 F-F3 strain, which possesses attenuation markers such as ts phenotype and reduced immunogenicity, was obtained. The mutant F-F3 strain did not affect the lungs in infected Syrian hamsters, unlike the parental strain, but retained viability in the nasal passages and immunogenicity. A single intranasal immunization of hamsters with the F-F3 ts strain caused seroconversion in them with the production of neutralizing antibodies. An important characteristic of F-F3 strain is low transmissibility and the stability of attenuation phenotype when cultured at 33°C.
Conclusions. The combination of the identified characteristics of the attenuated SARS-CoV-2 F-F3 strain indicates the rationality of further investigation of its safety and efficacy in an animal model of COVID-19.
205-215
The Effect of an Innovative Thiadiazine-Class Antibacterial Agent on the Motility of Vibrio cholerae
Abstract
Introduction. Vibrio cholerae motility plays a key role in the pathogenesis of cholera, so finding ways to suppress it is a promising approach to combating this infection.
Objective: to study the effect of Fluorothiazinone on the motility of V. cholerae.
Materials and methods. Flagellar motility was determined in 0.3% agar, with the motility zone measured, in 40 strains V. cholerae El Tor of varying epidemiological significance. The ability of these strains to acquire resistance to Fluorothiazinone was also assessed through repeated subcultures on alkaline agar containing Fluorothiazinone (100 mg/L).
Results. A significant decrease in the motility of all studied cultures was observed in the presence of Fluorothiazinone, without the development of resistance.
Conclusion. The dose-dependent ability of Fluorothiazinone to reduce the motility of V. cholerae was demonstrated for the first time.
229-235
Molecular epidemiology of the nosocomial Salmonella Typhimurium ST328 clone based on whole-genome sequencing data
Abstract
Background. Salmonella enterica serovar Typhimurium remains one of the leading causes of acute bacterial gastroenteritis worldwide. The emergence and dissemination of high-risk clones with multidrug resistance and capacity for prolonged nosocomial circulation represents a serious public health threat.
Objective: Based on genomic data, to characterize S. Typhimurium ST328 isolates, including the determination of its population structure, phylogeography, and mechanisms of antimicrobial resistance in the context of the global S. Typhimurium population.
Materials and methods. Eleven S. Typhimurium isolates were recovered from children with nosocomial salmonellosis in Gomel, Belarus, in 2002. Minimum inhibitory concentrations (MICs) were determined by broth microdilution method. Extended-spectrum β-lactamase (ESBL) production was detected using the double-disk method. Whole-genome sequencing was performed on the Illumina MiSeq platform. Bioinformatic analysis included serogenotyping (SISTR), multilocus sequence typing (MLST), ribosomal MLST (rMLST), identification of resistance genes (ResFinder 4.1), and phylogenetic single-nucleotide polymorphism (SNP) analysis using the EnteroBase database.
Results. A total of 81.8% of isolates belonged to sequence type ST328 and ribosomal type rST60463. Phenotypically, 72.7% of strains exhibited resistance to third-generation cephalosporins, and 63.6% produced ESBL. The blaCTX-M-5 gene was detected in 77.8% of ST328 strains, which completely correlated with the phenotype. Phylogenetic analysis of 112 ST328 strains from 10 countries revealed two subgroups (rST1344 and rST60463), differing in geographic distribution and resistance profiles. Screening of 713,000 Salmonella genomes in EnteroBase confirmed that blaCTX-M-5 was associated exclusively with the ST328/rST60463 lineage.
Conclusions. The S. Typhimurium ST328/rST60463 clone, producing ESBL CTX-M-5, circulated in Belarus in 2002 and represents a high-risk epidemiological clone. The results underscore the importance of enhanced genomic surveillance of nosocomial pathogens using international databases.
216-228
Genetic polymorphism of the р66 gene of Borrelia bavariensis circulating in a natural focus and its association with Ixodid tick-borne borrelioses in the population of the Middle Urals
Abstract
Introduction. Ixodid tick–borne borrelioses (ITBB) is a naturally occurring focal vector-borne infection. The most common pathogens in Russia are Borrelia garinii, B. afzelii, and B. bavariensis. One of the key factors in their pathogenicity is the surface protein P66, encoded by p66 gene. The polymorphism of this gene in B. bavariensis has been poorly studied, and the frequency of its genetic variants in the development of ITBB infection in humans remains unclear.
Aim — to present the main results of a complex study of p66 gene polymorphism in B. bavariensis isolates circulating in the natural focus. Objective: to analyze the variability of p66 gene in B. bavariensis isolates from components of pathogen’s parasitic system in comparison with the frequency of nucleotide sequence variants of this gene in isolates from ITBB patients.
Materials and methods. The p66 gene loci were sequenced in 238 B. bavariensis isolates obtained from people with ITBB, as well as from Ixodes ticks (I. persulcatus, I. trianguliceps) and from small mammals of 8 species from a natural focus in the Middle Urals (58°.00′ N, 56°.15′ E; 58°.32′ N, 57°.43′ E).
Results. The generalized scheme of the transmission routes of ITBB pathogens is presented as the basis for their circulation in natural foci and possible polymorphism of p66 gene. Among the studied isolates, 12 variants of the gene locus encoding fragments of P66 protein were found, which bear various amino acid substitutions. The spectrum and ratio of different alleles in isolates from vectors and reservoir hosts were virtually identical - two variants were predominant, as was the case among isolates from sick people with ITBB.
Conclusion. Amino acid substitutions in P66 protein found in the two dominant allelic variants of B. bavariensis affect its conformational structure and presumably enhance the adhesive function of the ITBB pathogen, which allows them to be considered as targets for the development of preventive drugs.
236-245
Immunogenicity of candidate HFRS vaccines based on guinea pig models
Abstract
Introduction. Cases of hemorrhagic fever with renal syndrome (HFRS) have increased over the past ten years, including in regions previously non-endemic for HFRS. Approximately 98% of all cases in Russia are associated with Puumala hantavirus, while only about 2% of sporadic cases are caused by Hantaan, Amur, Seoul, Kurkino and Sochi hantaviruses. The main HFRS foci are located in the European part of Russia. In endemic areas, the risk of infection exists for all population groups, especially military personnel and workers in the forestry and agricultural sectors. The etiotropic therapy absence can be solved only through vaccination. However, licensed vaccines based on Hantaan or Seoul hantaviruses do not provide protection against Puumala hantavirus, for which no vaccines currently exist worldwide. An experimental vaccine (EV) for the prevention of HFRS, based on Puumala and Hantaan hantaviruses, has been developed at the Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of the Russian Academy of Sciences (Institute of Poliomyelitis).
The aim of the study is to determine the EV immunogenicity against HFRS in a guinea pig model using various immunisation schedules.
Materials and methods. The induction of neutralising antibodies (NAb) was assessed in the blood serum of guinea pigs following immunisation with mono- and bivalent EV by means of a neutralisation assay based on 50% suppression of focus-forming units in Vero E6 cell culture.
The results indicate the formation of a humoral immune response following EV immunisations. Immunogen administration induced the NAb production up to peak values followed by a decrease after certain intervals. Repeated EV administration showed similar NAb dynamics with prolonged circulation. Three variants involving double immunisation and a subsequent booster after one year were prioritised for clinical trials (0, 150, 300; 0, 14, 182, 364; 0, 30, 364).
Conclusion. This study indicates the development of a persistent and intense immune response, the strength of which depended on the EV immunisation schedule. The optimal timing for immunogen administration has been determined. The results of this study will be the basis for subsequent clinical trials of hantavirus vaccines.
246-257
Humoral immunity to seasonal and zoonotic influenza in the population of the Russian Federation in 2021–2025
Abstract
Introduction. Influenza A virus is one of the major global infectious threats. Along with seasonal epidemics, zoonotic influenza viruses (subtypes А(H5Nх), А(H7Nх), А(H9N2)) pose an increased risk, requiring constant monitoring of herd immunity.
The aim of the work was to study human blood sera against influenza viruses, both vaccine strains and virus strains with pandemic potential.
Materials and methods. Blood sera from healthy donors collected in different regions of the Russian Federation were tested in the hemagglutination inhibition (HI) assay with vaccine strains of influenza A and B viruses. Blood sera from individuals involved in poultry farming were tested in the hemagglutination inhibition and virus neutralization assays with avian influenza viruses.
Results. From 2021 to 2025, only a few samples were positivein the HI assay with A(H5Nx) influenza viruses, and approximately 1% of samples were positive in HI assay with A(H9N2) virus. All samples positive in the HI assay with A(H5) viruses were negative in the neutralization assay, and approximately 85% of samples positive in the HI assay with A(H9N2) virus contained virus-neutralizing antibodies.
Conclusion. By 2023–2024, humoral immunity to seasonal influenza, following its decline during the COVID-19 pandemic, was at levels typical of pre-pandemic seasons and generally met the recommendations of Rospotrebnadzor and the World Health Organization. Currently, influenza viruses with pandemic potential, such as subtypes A(H5N1) and A(H9N2), are not circulating in the human population in the Russian Federation. However, insufficient herd immunity to seasonal influenza viruses poses additional risks for the emergence and spread of new virus variants.
258-266
SCIENCE AND PRACTICE
Development and application of a method for detecting RNA of West Nile virus genotypes 1 and 2 based on loop-mediated isothermal amplification
Abstract
Introduction. West Nile fever (WNF) is a widespread zoonotic natural focal arbovirus infection. In Russia, intense WNF epidemics are observed in the south and southeast of the European part of the country. Etiotropic treatment and specific immunoprophylaxis for this disease in humans have not been developed. A promising approach to rapid diagnostics of WNV is the detection of pathogen RNA using reverse transcription loop-mediated isothermal amplification (RT-LAMP).
The objective is to develop a method for detecting RNA of West Nile virus (WNV) genotypes 1 and 2 using RT-LAMP with various detection options and to test it on clinical material and samples collected during epizootological monitoring.
Materials and methods. A comparative in silico analysis of WNV genomes was performed using the NCBI GenBank database. The presence of WNV RNA was confirmed by RT-PCR. Detection of RT-LAMP results was performed by gel electrophoresis, in real time, and by endpoint analysis using intercalating dyes. Analytical specificity was tested on clinical and field specimens, as well as cell cultures infected with WNV and heterologous microorganisms. Analytical sensitivity was assessed using a recombinant plasmid containing the target fragment of the WNV cDNA sequence.
Results. The 5'-UTR fragment and the WNV polyprotein gene locus encoding the capsid protein were selected as the target. Eight unique LAMP primers were designed. The reaction mixture composition and RT-LAMP reaction conditions were optimized. The reverse transcription and amplification time was 45 minutes. The analytical sensitivity of the reaction was 5 × 103 GE/mL, and the analytical specificity was 100%, comparable to PCR.
Conclusion. The use of the designed primer set enables rapid, highly sensitive, and specific detection of WNV genotypes 1 and 2 RNA in field and clinical samples using RT-LAMP. The proposed method, along with existing developments for the detection of WNV based on PCR, is promising for molecular genetic diagnostics of WNV.
267-278
Reference values for gut microbiota parameters in rhesus macaques established by real-time polymerase chain reaction
Abstract
Introduction. Reference values for the gut microbiota are essential for a valid assessment of the health status of laboratory primates and for monitoring their keeping conditions. The obtained ranges of gut microbiota parameters are species-specific for rhesus macaques and cannot be directly extrapolated to humans. The results highlight the need to use age-specific norms for key taxa when interpreting the state of the microbiota in biomedical research.
Aim. To establish age-specific reference ranges for key taxa of the gut microbiota in rhesus macaques, detected by real-time PCR with the Kolonoflor-16 kit.
Materials and methods. The study utilized 120 fecal samples from clinically healthy rhesus macaques (Macaca mulatta) kept at the Kurchatov Complex of Medical Primatology. DNA extraction from fecal samples was performed using the Express-DNA-Bio kit (Alkor Bio) following a thermal lysis protocol. Quantitative analysis of 24 microbiological markers was conducted by real-time PCR using the Kolonoflor-16 kit (AlfaLab) on a CFX-96 thermocycler (Bio-Rad).
Results. Comprehensive age-specific reference ranges for the gut microbiota of rhesus macaques were established. Statistically significant ontogenetic trends reflecting consistent processes of microbial-host coadaptation were identified: a progressive decrease in the abundance of Lactobacillus spp. and Escherichia coli against an increase in Bacteroides spp. The stability of the total bacterial mass and the level of Faecalibacterium prausnitzii as a key butyrate producer throughout life was demonstrated. A pronounced age-related dynamics was observed for taxa that are commensals of the rhesus macaques gut. The detection rate of Akkermansia muciniphila increased from complete absence in infants to stabilization within species-typical limits in adults and elderly individuals, reflecting the maturation of the immune system and mucosal barrier. Enterococcus spp. was detected in all age groups and demonstrates variability in its quantitative values. The presence of Fusobacterium nucleatum in the studied sample is not associated with pathological conditions and is a species norm, not a marker of dysbiosis.
Conclusion. The data obtained using the real-time PCR method (KOLONOFLOR-16 kit) prove the inapplicability of human reference values for assessing the microbiota of monkeys and emphasize the need to use species- and age-specific criteria in scientific research.
279-289
OBITUARIES
290-290


